Ranbaxy faces quality questions

Concerns over lapses in quality at a laboratory in Ghana, where more than two thirds of the active pharmaceutical ingredient Ranbaxy uses to manufacture its US products.

Last week the US Food and Drug Administration (FDA) issued an alert for the Toansa, Ghana, plant, after it made eight observations during an inspection earlier this month, FiercePharma reported.

FiercePharma reported that the